Quick Answer
CV Sciences, Inc. reported Revenue (ASC 606) of $13.79 million for fiscal year 2025.
CV Sciences, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $13.79M | -12.2% |
| 2024 | $15.71M | -1.9% |
| 2023 | $16.00M | -1.2% |
| 2022 | $16.20M | -19.2% |
| 2021 | $20.05M | -17.9% |
| 2020 | $24.43M | -54.5% |
| 2019 | $53.70M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.26M | -15.8% | -10.1% |
| June 30, 2025 | $3.62M | -8.4% | +0.4% |
| March 31, 2025 | $3.61M | -9.9% | -6.7% |
| September 30, 2024 | $3.87M | -5.5% | -2.3% |
| June 30, 2024 | $3.95M | -0.3% | -1.2% |
| March 31, 2024 | $4.00M | -3.5% | -2.1% |
| September 30, 2023 | $4.09M | +9.0% | +3.1% |
| June 30, 2023 | $3.97M | -4.2% | -4.4% |
- CV Sciences, Inc. showed a decrease of -12.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2019–2025 period, CV Sciences, Inc.’s revenue (asc 606) has declined by 74.3% (from $53.70 million to $13.79 million).
- The most recent figure is from CV Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: